Irillic is a start-up company envisaged to create state-of-the-art niche and innovative products for the healthcare industry aimed to fulfill the need for cost effective unique solutions in diagnostics and treatment for human health. The company is formed by technocrats with wide and varying experience coming together to crystallize its vision. Irillic is involved in RnD, Product Engineering, Marketing and Sales of medical devices. Irillic is initially focused on medical imaging product for improving surgical outcomes and performing newer procedures. Irillic's first patented product is a medical imaging device used in Cancer surgeries, lymphatic surgeries, cardiac surgeries and many others. Our target projections for the next three years is about 500 units.

Momentum is derived from funding recency, velocity, round count and scale.

Indocyanine green fluorescence imaging enhances visibility during surgery. Find out how this technology improves patient outcomes now.

Other business activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Extracted from Irillic Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.